Skip to content

LeMaitre Vascular LMAT Net gains (losses) on investments

Net gains (losses) on investments at other companies

Merit Medical Systems logo
Merit Medical SystemsMMSI
-$531K
Axogen logo
AxogenAXGN
-$33K-173%
LivaNova logo
LivaNovaLIVN
$0+100%
ICU Medical logo
ICU MedicalICUI
-$607K

Other financials

Income statement

See full
Revenue$66.6M+11.2%
Gross profit$48.4M+16.8%
Operating income$17.8M+40.8%
Net income$15.7M+42.4%
EPS (diluted)$0.68+41.7%

Balance sheet

See full
Cash & equivalents$26.9M+6.0%
Total debt$20.9M+20.6%
Total equity$406.6M+17.0%
Total assets$629.5M+13.2%

Cash flow

See full
Operating cash flow$15.1M+67.0%
CapEx$2.8M+101%
Free cash flow$12.3M+60.8%

Valuation

See full
Market cap$2.1B+31.4%
Enterprise value$2.1B+31.6%
P/E33.7×-1.7×
P/S8.2×+1.1×

Profitability

See full
Gross margin72.4%+3.6pp
Operating margin28.5%+5.1pp
Net margin24.3%+4.4pp
FCF margin30.9%+12.7pp

Returns & leverage

See full
Return on equity16.5%+2.8pp
Debt / equity0.1×0.0×
Current ratio14.3×-2.2×

Where this comes from

Reported directly by LeMaitre Vascular in its filing.

Tagged under the XBRL concept us-gaap:UnrealizedGainLossOnInvestments.

The official record: LeMaitre Vascular’s 10-K, filed February 26, 2026, on SEC EDGAR. View the filing →

Ask your AI about LeMaitre Vascular's net gains (losses) on investments.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is LeMaitre Vascular's net gains (losses) on investments?
LeMaitre Vascular (LMAT) reported net gains (losses) on investments of -$133.75K in Q4 2025.
What does net gains (losses) on investments mean?
Realized and unrealized gains/losses on investments removed from operating cash flow since they're investing-related.